Feb 14 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2023 Dec 31, 2022 Mar 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 6.99 6.77 9.74
(+3.2 pct) (-7.7 pct) (+20.0 pct)
Operating 467 mln 1.36 625 mln
(-65.7 pct) (+27.1 pct) (-53.9 pct)
Recurring 546 mln 1.37 712 mln
(-60.1 pct) (+29.5 pct) (-46.9 pct)
Net 345 mln 856 mln 442 mln
(-59.7 pct) (+47.5 pct) (-45.5 pct)
EPS 43.56 yen 128.97 yen 55.16 yen
Ann Div 8.00 yen 8.00 yen
-Q2 div NIL NIL
-Q4 div 8.00 yen 8.00 yen
NOTE - Enbio Holdings, Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T